期刊文献+

辛伐他汀联合辅酶Q_(10)治疗充血性心力衰竭84例疗效观察

Therapeutic effects of simvastatin and coenzyme Q_(10) in treatment of congestive heart failure
下载PDF
导出
摘要 目的探讨他汀类药物联合辅酶Q10对慢性心力衰竭的治疗作用。方法将84例充血性心力衰竭患者随机分为辛伐他汀组(n=42)和对照组(n=42)。在常规治疗的基础上辛伐他汀组加用辛伐他汀和辅酶Q10,辛伐他汀起始剂量5mg/d,4周后增至10mg/d,辅酶Q1010mg,1天3次。结果治疗12周后,辛伐他汀组较对照组血浆总胆固醇和低密度脂蛋白水平降低,心功能改善,左室射血分数提高(P<0.01),血浆肿瘤坏死因子α(TNF-α)和白介素-6(IL-6)水平显著降低(P<0.01)。结论辛伐他汀可以显著改善心力衰竭患者的心功能和血管内皮功能,提示他汀类药物可用于治疗充血性心力衰竭。 Objective To research therapeutic effcets of simvastatin and ceenzyme Q10 in treatment of congestive heart failure. Methods Eighty-four patients with congestive heart failure were randomly divided into two groups:one group ( n = 42) received simvastatin and ceenzyme Q10 ;the other group( n =42) received regular treatment. On the basis of regular treatment,the initial dose of simvastatin was 5 mg/d and increased to 10mg/d after 4 weeks,and the dose of ceenzyme Q10 was 10mg,three times a day. Results After 12 weeks,the group receiving simvastatin exhibited a reduction in plasma chlolesterol and LDL compared to the contrast group. NYHA cardiac function class in simvastatin group was improved ,and left ventricular ejection fraction(LVEF) was increased in patients treated with simvastatin[ (39. 07 ±3.52) % vs (34. 07 ± 3.14) %, P 〈 0.01 ]. The plasma concentration of TNF-α and IL-6 were significant decreased in simvastatin group (P 〈 0. 01 ). Conclusions Simvastatin can improve cardiac and endothelial function in patients with congestive heart failure. It suggests that simvastatin may have therapeutic benefits in congestive heart failure.
出处 《中国厂矿医学》 2007年第5期465-466,共2页 Chinese Medicine of Factory and Mine
关键词 心力衰竭 辛伐他汀 辅酶Q10 Heart failure Simvastatin Coenzyme Q10
  • 相关文献

参考文献10

二级参考文献23

  • 1王安才,成蓓,谢晓竟,徐浩.阿托伐他汀对自发性高血压大鼠心室重构的影响[J].中国临床药理学与治疗学,2004,9(8):880-884. 被引量:32
  • 2张冬颖,覃数.他汀类药物改善心室重塑的研究进展[J].重庆医学,2004,33(10):1581-1583. 被引量:17
  • 3蔡文阳,吴平彬,林育群,肖德明,林建华,陈海庆.辛伐他汀改善慢性心力衰竭预后的临床观察[J].中国实用内科杂志,2005,25(4):338-339. 被引量:14
  • 4Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J]. Circulation, 2001 被引量:1
  • 5Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction [J]. Circulation, 2002, 105:868 被引量:1
  • 6Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy [J]. Circulation, 2001,104:317 被引量:1
  • 7Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J]. Circulation, 1998, 97:1129. 被引量:1
  • 8Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells [J]. Eur J Pharmacol, 1999, 376:139 被引量:1
  • 9Luo JD, Zhang WW, Zhang GP, et al. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis [J]. Clin Exp Pharmacol Physiol, 1999, 26:903 被引量:1
  • 10Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor [J]. Circulation, 2001,104:576 被引量:1

共引文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部